Weather Alert

U.S. ‘Pauses’ Johnson & Johnson Vaccine After Clotting Reports

Woman receiving an injection in her arm

The U.S. is recommending a “pause” in administrating the single-dose Johnson & Johnson COVID-19 vaccine to investigate reports of potentially dangerous blood clots.

In a joint statement Tuesday, the CDC and FDA said it was investigating clots and reduced platelet counts in six women post-vaccination.

All six were women between the ages of 18 and 48; one died and a second is hospitalized in critical condition.

More than 6.8 million doses of the Johnson & Johnson vaccine have been administered in the U.S.

 


Connect With Us Listen To Us On